Lv2
150 积分 2022-06-26 加入
Role of VEGFA/VEGFR2 signaling in predicting clinical outcomes of EGFR-TKI treatment in EGFR-mutant non-small cell lung cancer
19天前
已完结
ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage
2个月前
已完结
Molecular mechanisms of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
3个月前
已完结
Cracking the EGFR code: Cancer biology, resistance mechanisms, and future therapeutic frontiers
3个月前
已完结
Cancer incidence and mortality in China, 2022
3个月前
已完结
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
3个月前
已完结
Epigenomic analysis identifies DTP subpopulation using HOPX to develop targeted therapy resistance in lung adenocarcinoma
3个月前
已关闭
Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
3个月前
已完结
STAT3 signaling mediates EGFR-TKI resistance in non-small cell lung cancer by regulating stemness markers and telomerase, reversed by icaritin
3个月前
已完结
Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
4个月前
已完结
皖公网安备34019202002308
